These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 17067715

  • 1. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK.
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [Abstract] [Full Text] [Related]

  • 2. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY.
    Clin Immunol; 2014 Jan; 152(1-2):127-39. PubMed ID: 24667685
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W, Wang P, Li Z, Xu W, Dai L, Wang K, Zhang J.
    Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
    Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY.
    Cancer Lett; 2010 Mar 01; 289(1):32-9. PubMed ID: 19683863
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
    Ye H, Sun C, Ren P, Dai L, Peng B, Wang K, Qian W, Zhang J.
    Oncol Lett; 2013 Feb 01; 5(2):663-668. PubMed ID: 23420714
    [Abstract] [Full Text] [Related]

  • 16. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
    Imai H, Nakano Y, Kiyosawa K, Tan EM.
    Cancer; 1993 Jan 01; 71(1):26-35. PubMed ID: 8380118
    [Abstract] [Full Text] [Related]

  • 17. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J, Wang P, Han Z, Li T, Yi C, Qiu C, Yang Q, Sun G, Dai L, Shi J, Wang K, Ye H.
    Cancer Sci; 2022 Feb 01; 113(2):411-422. PubMed ID: 34821436
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
    Wang P, Song C, Xie W, Ye H, Wang K, Dai L, Zhang Y, Zhang J.
    J Immunol Res; 2014 Feb 01; 2014():512540. PubMed ID: 24822225
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.